Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 2
1994 2
1995 3
1996 5
1997 3
1999 4
2000 1
2001 1
2002 2
2003 1
2004 1
2005 1
2006 5
2007 2
2008 4
2009 2
2010 5
2011 5
2012 3
2013 7
2014 9
2015 14
2016 18
2017 9
2018 13
2019 12
2020 17
2021 21
2022 10
2023 15
2024 10
2025 13
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

199 results

Results by year

Filters applied: . Clear all
Page 1
Cell sensitivity assays: the MTT assay.
van Meerloo J, Kaspers GJ, Cloos J. van Meerloo J, et al. Among authors: cloos j. Methods Mol Biol. 2011;731:237-45. doi: 10.1007/978-1-61779-080-5_20. Methods Mol Biol. 2011. PMID: 21516412
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Heuser M, Freeman SD, Ossenkoppele GJ, Buccisano F, Hourigan CS, Ngai LL, Tettero JM, Bachas C, Baer C, Béné MC, Bücklein V, Czyz A, Denys B, Dillon R, Feuring-Buske M, Guzman ML, Haferlach T, Han L, Herzig JK, Jorgensen JL, Kern W, Konopleva MY, Lacombe F, Libura M, Majchrzak A, Maurillo L, Ofran Y, Philippe J, Plesa A, Preudhomme C, Ravandi F, Roumier C, Subklewe M, Thol F, van de Loosdrecht AA, van der Reijden BA, Venditti A, Wierzbowska A, Valk PJM, Wood BL, Walter RB, Thiede C, Döhner K, Roboz GJ, Cloos J. Heuser M, et al. Among authors: cloos j. Blood. 2021 Dec 30;138(26):2753-2767. doi: 10.1182/blood.2021013626. Blood. 2021. PMID: 34724563 Free PMC article.
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party.
Cloos J, Valk PJM, Thiede C, Döhner K, Roboz GJ, Wood BL, Walter RB, Wang S, Wierzbowska A, Wei AH, Wu D, Vergez F, Venditti A, van der Reijden BA, van de Loosdrecht AA, Tiong IS, Thol FR, Subklewe M, Roumier C, Reuvekamp T, Ravandi F, Preudhomme C, Plesa A, Othman J, Ossenkoppele GJ, Ofran Y, Mimoun A, Maurillo L, Majchrzak A, de Leeuw D, Kern W, Kim DDH, Ikoma-Colturato MRV, Haaksma LH, Guzman ML, Feuring M, Depreter B, Czyz A, Bücklein V, Baer C, Bachas C, Freeman SD, Buccisano F, Hourigan CS, Dillon R, Heuser M. Cloos J, et al. Blood. 2026 Mar 12;147(11):1147-1167. doi: 10.1182/blood.2025031480. Blood. 2026. PMID: 41397238 Review.
The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets.
Knol JC, Lyu M, Böttger F, Nunes Monteiro M, Pham TV, Rolfs F, Vallés-Martí A, Schelfhorst T, de Goeij-de Haas RR, Bijnsdorp IV, Wang S, Zhang F, A J, Westerman BA, Sitek B, Lehtiö J, Koster J, IJzermans JNM, van Laarhoven HWM, Bijlsma MF, Medema JP, Henneman AA, Piersma SR, Brakenhoff RH, Cloos J, Cordo' V, de Jong D, Kazemier G, Koppers-Lalic D, Labots M, Le Large TYS, Martens JWM, Meijerink JPP, Mumtaz M, Scheepbouwer C, Kibbelaar RE, Noske DP, Steenbergen RDM, van Grieken NCT, van Houdt W, Giovannetti E, van Leenders GJLH, Jonkers J, Liu T, Yan M, Zhan X, Guo T, Jimenez CR. Knol JC, et al. Among authors: cloos j. Cancer Cell. 2025 Jul 14;43(7):1328-1346.e8. doi: 10.1016/j.ccell.2025.05.003. Epub 2025 May 29. Cancer Cell. 2025. PMID: 40446800
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.
Schuurhuis GJ, Heuser M, Freeman S, Béné MC, Buccisano F, Cloos J, Grimwade D, Haferlach T, Hills RK, Hourigan CS, Jorgensen JL, Kern W, Lacombe F, Maurillo L, Preudhomme C, van der Reijden BA, Thiede C, Venditti A, Vyas P, Wood BL, Walter RB, Döhner K, Roboz GJ, Ossenkoppele GJ. Schuurhuis GJ, et al. Among authors: cloos j. Blood. 2018 Mar 22;131(12):1275-1291. doi: 10.1182/blood-2017-09-801498. Epub 2018 Jan 12. Blood. 2018. PMID: 29330221 Free PMC article. Review.
Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia.
Grob T, Sanders MA, Vonk CM, Kavelaars FG, Rijken M, Hanekamp DW, Gradowska PL, Cloos J, Fløisand Y, van Marwijk Kooy M, Manz MG, Ossenkoppele GJ, Tick LW, Havelange V, Löwenberg B, Jongen-Lavrencic M, Valk PJM. Grob T, et al. Among authors: cloos j. J Clin Oncol. 2023 Feb 1;41(4):756-765. doi: 10.1200/JCO.22.00715. Epub 2022 Oct 31. J Clin Oncol. 2023. PMID: 36315929 Free PMC article.
Acute myeloid leukemia: does sex matter?
Tettero JM, Cloos J, Bullinger L. Tettero JM, et al. Among authors: cloos j. Leukemia. 2024 Nov;38(11):2329-2331. doi: 10.1038/s41375-024-02435-z. Epub 2024 Oct 14. Leukemia. 2024. PMID: 39402216 Free PMC article. Review. No abstract available.
Proteasome inhibitors in acute leukemia.
Niewerth D, Dingjan I, Cloos J, Jansen G, Kaspers G. Niewerth D, et al. Among authors: cloos j. Expert Rev Anticancer Ther. 2013 Mar;13(3):327-37. doi: 10.1586/era.13.4. Expert Rev Anticancer Ther. 2013. PMID: 23477519 Review.
199 results